CBUS Key Statistics, Chart & Performance
The current stock price of CBUS is 1.64 USD. In the past month the price increased by 30.68%. In the past year, price decreased by -60.95%.
CBUS Latest News, Press Relases and Analysis
CBUS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 23.92 | 399.57B | ||
| AMGN | AMGEN INC | 15.08 | 177.64B | ||
| GILD | GILEAD SCIENCES INC | 14.8 | 150.40B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 26.24 | 115.56B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.96 | 75.50B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 898.27 | 60.52B | ||
| INSM | INSMED INC | N/A | 43.51B | ||
| NTRA | NATERA INC | N/A | 33.75B | ||
| BIIB | BIOGEN INC | 10.83 | 26.60B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.54 | 21.07B | ||
| INCY | INCYTE CORP | 15.97 | 20.13B | ||
| EXAS | EXACT SCIENCES CORP | N/A | 19.18B |
Related stock screener links
About CBUS
Company Profile
Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. The company is headquartered in San Diego, California and currently employs 157 full-time employees. The company went IPO on 2017-07-20. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). The company is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. The company has a pipeline of five productivity traits. The company has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
Company Info
CIBUS INC
6455 Nancy Ridge Drive
San Diego CALIFORNIA US
Employees: 158
Phone: 18584500008
CIBUS INC / CBUS FAQ
Can you describe the business of CIBUS INC?
Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. The company is headquartered in San Diego, California and currently employs 157 full-time employees. The company went IPO on 2017-07-20. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). The company is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. The company has a pipeline of five productivity traits. The company has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
What is the current price of CBUS stock?
The current stock price of CBUS is 1.64 USD. The price increased by 1.86% in the last trading session.
What is the dividend status of CIBUS INC?
CBUS does not pay a dividend.
What is the ChartMill technical and fundamental rating of CBUS stock?
CBUS has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Which stock exchange lists CBUS stock?
CBUS stock is listed on the Nasdaq exchange.
What is the Price/Earnings (PE) ratio of CIBUS INC (CBUS)?
CIBUS INC (CBUS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.66).
Can you provide the market cap for CIBUS INC?
CIBUS INC (CBUS) has a market capitalization of 89.02M USD. This makes CBUS a Micro Cap stock.
CBUS Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to CBUS. When comparing the yearly performance of all stocks, CBUS is a bad performer in the overall market: 82.31% of all stocks are doing better.
CBUS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CBUS. Both the profitability and financial health of CBUS have multiple concerns.
CBUS Financial Highlights
Over the last trailing twelve months CBUS reported a non-GAAP Earnings per Share(EPS) of -2.66. The EPS increased by 82.01% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -79.54% | ||
| ROE | -381.79% | ||
| Debt/Equity | 0 |
CBUS Forecast & Estimates
10 analysts have analysed CBUS and the average price target is 14.69 USD. This implies a price increase of 795.61% is expected in the next year compared to the current price of 1.64.
For the next year, analysts expect an EPS growth of 18.82% and a revenue growth 0.81% for CBUS